TNSN04120A1 - Derives de 5-(pyridin-3-yl)-1-azabicyclo [3.2.1] octane, leur preparation et leur application en therapeutique - Google Patents

Derives de 5-(pyridin-3-yl)-1-azabicyclo [3.2.1] octane, leur preparation et leur application en therapeutique

Info

Publication number
TNSN04120A1
TNSN04120A1 TNP2004000120A TNSN04120A TNSN04120A1 TN SN04120 A1 TNSN04120 A1 TN SN04120A1 TN P2004000120 A TNP2004000120 A TN P2004000120A TN SN04120 A TNSN04120 A TN SN04120A TN SN04120 A1 TNSN04120 A1 TN SN04120A1
Authority
TN
Tunisia
Prior art keywords
group
azabicyclo
pyridin
octane
derivatives
Prior art date
Application number
TNP2004000120A
Other languages
English (en)
French (fr)
Inventor
Alain Nedelec
Odile Leclerc
Frédéric Galli
Alistair Lochead
Original Assignee
Sanofi - Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi - Aventis filed Critical Sanofi - Aventis
Publication of TNSN04120A1 publication Critical patent/TNSN04120A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TNP2004000120A 2002-01-07 2004-06-30 Derives de 5-(pyridin-3-yl)-1-azabicyclo [3.2.1] octane, leur preparation et leur application en therapeutique TNSN04120A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200109A FR2834511B1 (fr) 2002-01-07 2002-01-07 Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
PCT/FR2003/000004 WO2003057697A1 (fr) 2002-01-07 2003-01-03 Derives de 5-(pyridin-3-yl)-1-azabicyclo [3.2.1] octane, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
TNSN04120A1 true TNSN04120A1 (fr) 2006-06-01

Family

ID=8871176

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2004000120A TNSN04120A1 (fr) 2002-01-07 2004-06-30 Derives de 5-(pyridin-3-yl)-1-azabicyclo [3.2.1] octane, leur preparation et leur application en therapeutique

Country Status (35)

Country Link
US (2) US7223750B2 (cg-RX-API-DMAC7.html)
EP (1) EP1465893B1 (cg-RX-API-DMAC7.html)
JP (1) JP4402957B2 (cg-RX-API-DMAC7.html)
KR (1) KR100977332B1 (cg-RX-API-DMAC7.html)
CN (2) CN1911928A (cg-RX-API-DMAC7.html)
AR (2) AR038098A1 (cg-RX-API-DMAC7.html)
AT (1) ATE355290T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003216777B2 (cg-RX-API-DMAC7.html)
BR (1) BR0306707A (cg-RX-API-DMAC7.html)
CA (1) CA2471628C (cg-RX-API-DMAC7.html)
CO (1) CO5590914A2 (cg-RX-API-DMAC7.html)
CY (1) CY1106580T1 (cg-RX-API-DMAC7.html)
DE (1) DE60312123T2 (cg-RX-API-DMAC7.html)
DK (1) DK1465893T3 (cg-RX-API-DMAC7.html)
EA (1) EA007793B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP045176A (cg-RX-API-DMAC7.html)
ES (1) ES2281631T3 (cg-RX-API-DMAC7.html)
FR (1) FR2834511B1 (cg-RX-API-DMAC7.html)
HR (1) HRP20040617B1 (cg-RX-API-DMAC7.html)
IL (2) IL162524A0 (cg-RX-API-DMAC7.html)
IS (1) IS2470B (cg-RX-API-DMAC7.html)
MA (1) MA27165A1 (cg-RX-API-DMAC7.html)
ME (2) ME00213B (cg-RX-API-DMAC7.html)
MX (1) MXPA04006630A (cg-RX-API-DMAC7.html)
NO (1) NO329309B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ533793A (cg-RX-API-DMAC7.html)
PL (1) PL216665B1 (cg-RX-API-DMAC7.html)
PT (1) PT1465893E (cg-RX-API-DMAC7.html)
RS (1) RS50921B (cg-RX-API-DMAC7.html)
SI (1) SI1465893T1 (cg-RX-API-DMAC7.html)
TN (1) TNSN04120A1 (cg-RX-API-DMAC7.html)
TW (1) TWI336703B (cg-RX-API-DMAC7.html)
UA (1) UA77229C2 (cg-RX-API-DMAC7.html)
WO (1) WO2003057697A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200405002B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902007D0 (en) * 1999-01-30 1999-03-17 Thomas Carpentry Services Limi Improvements relating to door frames
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
FR2889701B1 (fr) 2005-08-12 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.
FR2889847B1 (fr) * 2005-08-18 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique.
FR2912404B1 (fr) * 2007-02-09 2009-04-10 Sanofi Aventis Sa Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
KR101928505B1 (ko) * 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
KR101925971B1 (ko) * 2011-01-28 2018-12-06 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
ES3064457T3 (en) 2017-11-03 2026-04-24 Alcon Inc Azabicyclo derivatives for treating ocular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
WO1995003306A1 (en) 1993-07-22 1995-02-02 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
FR2786770B1 (fr) * 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2786769B1 (fr) * 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
RS59904A (sr) 2006-10-27
CO5590914A2 (es) 2005-12-30
EP1465893A1 (fr) 2004-10-13
IL162524A (en) 2010-05-17
FR2834511B1 (fr) 2004-02-13
NO329309B1 (no) 2010-09-27
MA27165A1 (fr) 2005-01-03
TWI336703B (en) 2011-02-01
MXPA04006630A (es) 2004-11-10
ECSP045176A (es) 2004-08-27
US7585974B2 (en) 2009-09-08
BR0306707A (pt) 2005-02-09
EA200400770A1 (ru) 2004-12-30
CN1612876A (zh) 2005-05-04
EA007793B1 (ru) 2007-02-27
EP1465893B1 (fr) 2007-02-28
PL370065A1 (en) 2005-05-16
UA77229C2 (uk) 2006-11-15
HK1066547A1 (en) 2005-03-24
JP4402957B2 (ja) 2010-01-20
IL162524A0 (en) 2005-11-20
PT1465893E (pt) 2007-05-31
AR086573A2 (es) 2014-01-08
US7223750B2 (en) 2007-05-29
ZA200405002B (en) 2006-05-31
CA2471628C (en) 2011-03-22
MEP24408A (en) 2010-10-10
HRP20040617B1 (hr) 2012-10-31
KR20040077705A (ko) 2004-09-06
AR038098A1 (es) 2004-12-29
DE60312123D1 (de) 2007-04-12
CA2471628A1 (en) 2003-07-17
US20070185137A1 (en) 2007-08-09
SI1465893T1 (sl) 2007-08-31
ME00213B (me) 2011-02-10
CN1276921C (zh) 2006-09-27
IS7322A (is) 2004-06-16
RS50921B (sr) 2010-08-31
ES2281631T3 (es) 2007-10-01
NO20042846L (no) 2004-09-21
PL216665B1 (pl) 2014-04-30
DE60312123T2 (de) 2007-09-13
HRP20040617A2 (en) 2004-10-31
CN1911928A (zh) 2007-02-14
US20050020568A1 (en) 2005-01-27
AU2003216777B2 (en) 2008-10-02
FR2834511A1 (fr) 2003-07-11
TW200305413A (en) 2003-11-01
DK1465893T3 (da) 2007-06-04
WO2003057697A1 (fr) 2003-07-17
CY1106580T1 (el) 2012-01-25
AU2003216777A1 (en) 2003-07-24
JP2005514422A (ja) 2005-05-19
NZ533793A (en) 2007-01-26
KR100977332B1 (ko) 2010-08-20
IS2470B (is) 2008-12-15
ATE355290T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
MA27390A1 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
ES2163295T3 (es) Derivados de imidazol y su uso como inhibidores de la farnesil-protein-transferasa.
BR0014133A (pt) Uso de um composto, composto, métodos de preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica
BR0014137A (pt) Composto, método para inibir a aurora 2 quinase em um animal de sangue quente, uso de um composto, e, composição farmacêutica
DE69813896D1 (de) Alpha-aminoamidderivate die als analgetische mittel nützlich sind
EA199800882A1 (ru) Производные замешенных индазолов, их применение в качестве ингибиторов фосфодиэстеразы (фдэ) iv и получение фактора некроза опухолей (фно)
WO1999028304A3 (en) Pdgf receptor kinase inhibitory compounds, their preparation and compositions
EA200700099A1 (ru) Производные пиридина
BR0014136A (pt) Composto, uso do mesmo, métodos para a preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica
BRPI9608082A (pt) derivado de quinazolina, sal de cloridreto do mesmo, e, composição farmacêutica
BR0307409A (pt) Compostos de hidrazida de ácido 2-furanocarboxìlico, composições farmacêuticas contendo os mesmos e uso dos mesmos para preparação de um agente preventivo ou terapêutico
BRPI0409110A (pt) derivados de 4-(4-heterociclilalcoxi)fenil-1-(heterociclil-carboni l)piridina e compostos relacionados como antagonistas de histamina h3 para o tratamento de doenças neurológicas tais como alzheimer
TNSN06439A1 (fr) Derives de 2-carbamide -4-phenylthiazole, leur preparation et leur application en therapeutique
BR9808552A (pt) Composto tricìclico ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
FR2856684A1 (fr) Derives de diphenylpyridine, leur preparation et leur application en therapeutique
EA200400770A1 (ru) Производные 5-(пиридин-3-ил)-1-азабицикло[3.2.1]октана, их получение и применение в терапии
IE960774L (en) Arylalkylamides having neuroprotective properties
BRPI0417308A (pt) compostos, respectivo uso, composição farmacêutica, métodos de tratamento de distúrbios mediados pelo receptor mglur5 e de inibição da ativação de receptores mglur5 e processo de produção de compostos de piridila
RU2000111500A (ru) Фармацевтические комбинированные препараты
JPS6233172A (ja) ド−パミン−β−ヒドロキシラ−ゼ抑制剤
YU16196A (sh) Upotreba novih benzohinolin-3-ona i njihovih farmaceutski prihvatljivih soli za proizvodnju leka
NO20023381D0 (no) Indolderivater som MCP-1-reseptoragonister
OA09324A (fr) "Procédé de préparation de (pyridyl-3)-2 tétrahydrothiopyrannecarbothioamide-2-oxydes-1-(1R,2R), les (pyridyl-3)-2 tétrahydrothiopyrannecarbothioamide-2-oxydes-1-(1R,2R) ainsi obtenus et les compositions pharmaceutiques qui les contiennent".
MA27096A1 (fr) Nouveaux dérivés de benzo[a]pyrano[3,2-h]acridin-7-one, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
RU2015151257A (ru) Фармацевтическое применение соединения гексагидродибензо[a, g]хинолизина